Histology, grade, myometrial invasion, lymphovascular space invasion (LVSI), tumor size, peritoneal cytology, hormone receptor status, ploidy and markers, body mass index (BMI), and the therapy received are other prognostic markers. Here, NR4A1 is linked to neoplasm.